Oncolytics Biotech (TSE:ONC) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Oncolytics Biotech, a leader in immunotherapy for cancer, has announced a conference call to discuss its second quarter financial results and recent company developments. The event is scheduled for August 1, 2024, and will cover corporate updates and financial performance, highlighting the progress of their leading immunotherapeutic agent, pelareorep.
For further insights into TSE:ONC stock, check out TipRanks’ Stock Analysis page.
